iBio announces production of biosimilar rituximab drug, shares rallyProactive Investors UKiBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technology has been used to produce a functional,…
Jonah Lomu Approved of Kidney Transplantation – TopNews New Zealand
TopNews New ZealandJonah Lomu Approved of Kidney TransplantationTopNews New ZealandJonah Lomu will be undergoing another Kidney transplantation surgery as his earlier transplantation has failed to work. The rugby player had undergone the transplantatio…
Robotic versus laparoscopic partial nephrectomy for bilateral synchronous … – UroToday
Robotic versus laparoscopic partial nephrectomy for bilateral synchronous …UroTodayThe median warm ischemia time was shorter in the RPN group than in the LPN group (19 vs 37 minutes, respectively; P = .059). The median tumor size was 2.85 and 2.7 cm …
iBio announces production of biosimilar rituximab drug, shares rally – Proactive Investors USA & Canada
Proactive Investors USA & CanadaiBio announces production of biosimilar rituximab drug, shares rallyProactive Investors USA & CanadaiBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technol…
iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ Technology – Sacramento Bee
iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ TechnologySacramento BeeRituximab is a chimeric mouse-human monoclonal antibody that binds to the CD20 antigen presented on the B-cell surface. Scientists at iBio's research a…
Voclosporin study published in the American Journal of Transplantation – Canada NewsWire (press release)
Voclosporin study published in the American Journal of TransplantationCanada NewsWire (press release)The primary endpoint of the study was to demonstrate noninferiority of at least one of the three VCS groups in preventing acute rejection compared to T…
iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ Technology – PR Newswire (press release)
iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ TechnologyPR Newswire (press release)… production of biotherapeutic proteins and vaccine antigens in whole green plants has been used to produce a functional monoclonal antibody…
Complications of Chronic Kidney Disease Occur Earlier in Children – Kansas City infoZine
MedIndiaComplications of Chronic Kidney Disease Occur Earlier in ChildrenKansas City infoZineWashington, DC – infoZine – In what may lead to a shift in treatment, the largest prospective study of children with chronic kidney disease (CKD) has confirmed…
Merck KGaA signs MS and cancer research deal – InPharm
InPharmMerck KGaA signs MS and cancer research dealInPharmIn August Biogen and Abbott's MS drug daclizumab, a new injectable, performed well in a Phase IIb study, although two deaths marred the overall results. But Novartis' oral drug Gilenya (…
CBS News correspondent brings his most difficult story to Billings – KTVQ Billings News
CBS News correspondent brings his most difficult story to BillingsKTVQ Billings NewsBrain death. It takes those diagnosed, between five to twenty years to die. Alzheimer's is why CBS News Senior Correspondent Barry Petersen is in Billings this week…